Moleculin Biotech grants CFO Jonathan Foster 260,000 stock options and 260,000 restricted stock units

Moleculin Biotech granted Chief Financial Officer Jonathan P. Foster 260,000 stock options on October 15, 2026. Foster also received 260,000 restricted stock units on the same date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032864), on October 16, 2026, and is solely responsible for the information contained therein. (C)